EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epidemiology of Hospitalized Heart Failure in France Based on National Data Over 10 Years, 2012–2022

Valérie Olié, Richard Isnard, Françoise Pousset, Clémence Grave, Jacques Blacher, Amélie Gabet iD

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Valérie Olié und 5 weiteren Autor:innen. Beteiligte Einrichtung: Santé Publique France, Saint-Maurice, France. Hauptthemen laut MEDLINE: Heart Failure, Hospitalization, COVID-19. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We aim to describe the incidence of HF hospitalization in France in the post-pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio-economic differences and to analyse time-trends between 2012 and 2022. Methods and results Based on the French health care database providing medical information for almost the whole French population, patients hospitalized for acute decompensated HF without history of HF in the 5 years were identified by the International Classification of Diseases – 10th revision (ICD-10) codes. In 2022, the estimated prevalence of HF was 1.7% in France and has increased until the COVID-19 pandemic and decreased thereafter. The incidence of acute HF decompensation reached 201.4 per 100 000 inhabitants and has decreased since 2012 (−1% per year). A significant increase of the HF incidence was found in men aged <45 years. Women aged <65 years were less likely to be admitted in a cardiac rehabilitation (CR) unit and had higher probability of one-year mortality compared with men of the same age. One-year mortality was significantly increased in patients from the most deprived area among extreme age group only (under 65 and ≥85 years). One-year rehospitalization rates have decreased significantly, particularly in men aged <75 years. A decrease in ACE/ARBs deliveries was observed in both men and women.

Conclusions

Despite the decrease in acute HF decompensation incidence and improvements in the management, the prevalence of HF remains stable in France and prognosis remains poor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHospitalizationCOVID-19HumansFranceFemaleMaleAgedMiddle AgedIncidenceAged, 80 and overPrevalenceAdultSARS-CoV-2

Stichwörter der Autor:innen

Heart failureHospitalizationsIncidenceOutcomesPrevalenceTime‐trends

Autor:innen und Institutionen

  • Santé Publique France, Saint-Maurice, France.
  • AP-HP, Pitié-Salpêtrière, Paris, France.
  • AP-HP, Hôtel-Dieu, Paris, France.

ORCID-Profile: Amélie Gabet

Zitieren

APA

Olié, V., Isnard, R., Pousset, F., Grave, C., Blacher, J., & Gabet, A. (2025). Epidemiology of Hospitalized Heart Failure in France Based on National Data Over 10 Years, 2012–2022. ESC Heart Failure. https://doi.org/10.1002/ehf2.15137

Vancouver

Olié V, Isnard R, Pousset F, Grave C, Blacher J, Gabet A. Epidemiology of Hospitalized Heart Failure in France Based on National Data Over 10 Years, 2012–2022. ESC Heart Failure. 2025. doi:10.1002/ehf2.15137

BibTeX
@article{Oli2025,
  author = {Olié, Valérie and Isnard, Richard and Pousset, Françoise and Grave, Clémence and Blacher, Jacques and Gabet, Amélie},
  title = {Epidemiology of Hospitalized Heart Failure in France Based on National Data Over 10 Years, 2012–2022},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15137}
}
Kostenlos starten →